Emflaza

Deflazacort

Emflazaは、満5歳以上の患者のデュシェンヌ型筋ジストロフィー(DMD)の治療のために指示されたコルチコステロイドである。
more
パッケージ あたり 錠剤 価格 節約 ご注文
180 tablet
¥ 102.74
¥ 18493.72¥ 102.74
¥ 32696.66
120 tablet
¥ 118.54
¥ 14224.29¥ 118.54
¥ 19902.63
90 tablet
¥ 142.24
¥ 12801.15¥ 142.24
¥ 12794.04
60 tablet
¥ 177.77
¥ 10666.44¥ 177.77
¥ 6397.02
30 tablet
¥ 284.39
¥ 8531.73¥ 284.39
パッケージ あたり 錠剤 価格 節約 ご注文
120 tablet
無料航空便配送 Hot
¥ 652.21
¥ 78265.64¥ 652.21
¥ 14202.95
90 tablet
無料航空便配送 Hot
¥ 687.77
¥ 61899.52¥ 687.77
¥ 7451.92
60 tablet
無料航空便配送 Hot
¥ 711.45
¥ 42687.11¥ 711.45
¥ 3547.18
36 tablet
無料航空便配送 Hot
¥ 750.90
¥ 27032.56¥ 750.90
¥ 708.01
24 tablet
¥ 770.57
¥ 18493.72¥ 770.57
パッケージ あたり 錠剤 価格 節約 ご注文
90 tablet
無料航空便配送 Hot
¥ 790.55
¥ 71149.93¥ 790.55
¥ 14211.84
60 tablet
無料航空便配送 Hot
¥ 853.77
¥ 51225.96¥ 853.77
¥ 5681.89
36 tablet
無料航空便配送 Hot
¥ 909.03
¥ 32725.13¥ 909.03
¥ 1419.58
24 tablet
無料航空便配送 Hot
¥ 948.46
¥ 22763.14¥ 948.46
Emflaza

ブランド

製造元

  • Lupin

病衣

  • Duchenne Muscular Dystrophy / DMD

Deflazacort tablets

What is this medicine?

Deflazacort a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.

What should I tell my health care providers before I take this medicine?

They need to know if you have any of these conditions:

  • Hypersensitivity to deflazacort;
  • Alterations in Endocrine Function: Hypothalamic-pituitary-adrenal axis suppression, Cushing’s syndrome, and hyperglycemia;
  • Immunosuppression and Increased Risk of Infection: Increased risk of new, exacerbation, dissemination, or reactivation of latent infections, which can be severe and at times fatal;
  • Alterations in Cardiovascular/Renal Function: elevated blood pressure and sodium, and for decreased potassium level;
  • Gastrointestinal Perforation: GI disorders;
  • Behavioral and Mood Disturbances: euphoria, insomnia, mood swings, personality changes, severe depression, and psychosis;
  • Effects on Bones: decreases in bone mineral density;
  • Serious Skin Rashes;
  • Ophthalmic Effects: May include cataracts, infections, and glaucoma;
  • Vaccination: Do not administer live or live attenuated vaccines to patients receiving immunosuppressive doses of corticosteroids.

How should I use this medicine?

The recommended once-daily dosage is approximately 0.9 mg/kg/day administered orally. Discontinue gradually when administered for more than a few day..

What may interact with this medicine?

  • Moderate or strong CYP3A4 inhibitors: Give one third of the recommended dosage;
  • Avoid use of moderate or strong CYP3A4 inducers, as they may reduce efficacy.

What side effects may I notice from this medicine?

The most common adverse reactions are Cushingoid appearance, weight increased, increased appetite, upper respiratory tract infection, cough, pollakiuria, hirsutism, central obesity, and nasopharyngitis.